247 related articles for article (PubMed ID: 28403963)
21. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.
Jiang YC; Ma JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3286-3293. PubMed ID: 29917177
[TBL] [Abstract][Full Text] [Related]
22. Defective CFTR-regulated granulosa cell proliferation in polycystic ovarian syndrome.
Chen H; Guo JH; Zhang XH; Chan HC
Reproduction; 2015 May; 149(5):393-401. PubMed ID: 25646509
[TBL] [Abstract][Full Text] [Related]
23. Expression of ARID1A in polycystic ovary syndrome and its effect on the proliferation and apoptosis of ovarian granulosa cells.
Ji XL; Liu X; Wang Z; Fang YC
Ann Endocrinol (Paris); 2020 Dec; 81(6):521-529. PubMed ID: 33290750
[TBL] [Abstract][Full Text] [Related]
24. Deregulation of WNT2/FZD3/β-catenin pathway compromises the estrogen synthesis in cumulus cells from patients with polycystic ovary syndrome.
Qiao GY; Dong BW; Zhu CJ; Yan CY; Chen BL
Biochem Biophys Res Commun; 2017 Nov; 493(1):847-854. PubMed ID: 28709873
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome.
Zhang J; Zhu G; Wang X; Xu B; Hu L
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):311-4. PubMed ID: 17641850
[TBL] [Abstract][Full Text] [Related]
26. Aberrant activation of the Hedgehog signaling pathway in granulosa cells from patients with polycystic ovary syndrome.
Li Y; Xiong G; Tan J; Wang S; Wu Q; Wan L; Zhang Z; Huang O
Bioengineered; 2021 Dec; 12(2):12123-12134. PubMed ID: 34873972
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome.
Li Y; Xiang Y; Song Y; Wan L; Yu G; Tan L
Mol Hum Reprod; 2019 Oct; 25(10):638-646. PubMed ID: 30865275
[TBL] [Abstract][Full Text] [Related]
28. Does endoplasmic reticulum stress stimulate the apoptosis of granulosa cells in polycystic ovary syndrome?
Sun HL; Tian MM; Jiang JX; Liu CJ; Zhai QL; Wang CY; Li QC; Wang YL
J Physiol Pharmacol; 2021 Oct; 72(5):. PubMed ID: 35288480
[TBL] [Abstract][Full Text] [Related]
29. Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells-A study in PCOS patients.
Belani M; Deo A; Shah P; Banker M; Singal P; Gupta S
J Steroid Biochem Mol Biol; 2018 Apr; 178():283-292. PubMed ID: 29339197
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression levels of BMP15/Smad1 are associated with granulosa cell apoptosis in patients with polycystic ovary syndrome.
Cui X; Jing X; Wu X; Bi X; Liu J; Long Z; Zhang X; Zhang D; Jia H; Su D; Huo K
Mol Med Rep; 2017 Dec; 16(6):8231-8236. PubMed ID: 28983616
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome: anomalies in progesterone production.
Doldi N; Gessi A; Destefani A; Calzi F; Ferrari A
Hum Reprod; 1998 Feb; 13(2):290-3. PubMed ID: 9557824
[TBL] [Abstract][Full Text] [Related]
32. Role of Androgen Receptor for Reconsidering the "True" Polycystic Ovarian Morphology in PCOS.
Gao XY; Liu Y; Lv Y; Huang T; Lu G; Liu HB; Zhao SG
Sci Rep; 2020 Jun; 10(1):8993. PubMed ID: 32488141
[TBL] [Abstract][Full Text] [Related]
33. Glioma-Associated Oncogene Family Zinc Finger 2 (GLI2) Activates Wnt Signaling through Transcriptional Inhibition of Neuronal Precursor Cell-Expressed Developmentally Downregulated 4 (NEDD4L) to Promote Androgen-Induced Granulosa Cell Damage.
Zhang Y; Wang J; Zheng Y; Zhu T; Shen M; He P
Ann Clin Lab Sci; 2023 Jan; 53(1):52-63. PubMed ID: 36889770
[TBL] [Abstract][Full Text] [Related]
34. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
35. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
36. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.
Willis D; Mason H; Gilling-Smith C; Franks S
J Clin Endocrinol Metab; 1996 Jan; 81(1):302-9. PubMed ID: 8550768
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome.
He T; Liu Y; Zhao S; Liu H; Wang Z; Shi Y
Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():134-140. PubMed ID: 30594023
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic silencing of SFRP5 promotes the metastasis and invasion of chondrosarcoma by expression inhibition and Wnt signaling pathway activation.
Sheng W; Zhang ZC; Shi DY; Wang BC; Wu Q; Shao ZW; Yang SH; He TC; Liu JX
Chem Biol Interact; 2018 Dec; 296():1-8. PubMed ID: 30125549
[TBL] [Abstract][Full Text] [Related]
39. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
Almario RU; Karakas SE
Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371
[TBL] [Abstract][Full Text] [Related]
40. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
Sagnella F; Apa R; Guido M; Villa P; Spadoni V; Miceli F; Lanzone A
Fertil Steril; 2009 May; 91(5):1857-63. PubMed ID: 18538325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
